Ligand Updates License Agreement with Exelixis
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Ligand to Hold Third Quarter Results Conference Call on November 5
PROMACTA Awarded 2009 Prix Galien for Best Biotechnology Product
Ligand to Present on October 6th at the Fourth Annual JMP Securities Healthcare Focus Conference
Ligand and GlaxoSmithKline Collaboration Identifies New Compound
Ligand Presents to Investors at Thomas Weisel Partners Healthcare Conference
Ligand to Present at Thomas Weisel Partners on September 9
Ligand to Acquire Neurogen for Stock and Contingent Value Rights
Ligand Terminates Long-Term Lease Obligation
Ligand Pharmaceuticals Announces Second Quarter Results
Ligand and Organon Mutually Terminate Collaboration and License Agreement
Ligand to Hold Second Quarter Results Conference Call on August 3
Ligand Licenses Patents for Desulfated Heparin Technology to ParinGenix
